Topical Drug Delivery Market
PUBLISHED: 2022 ID: SMRC21699
SHARE
SHARE

Topical Drug Delivery Market

Topical Drug Delivery Market Forecasts to 2028 - Global Analysis By Product (Liquid Formulations, Solid Formulations, Devices (Transdermal Drug Delivery), Semi-Solid Formulations), and By Geography

4.1 (18 reviews)
4.1 (18 reviews)
Published: 2022 ID: SMRC21699

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2020-2028

Estimated Year Value (2022)

US $109.80 BN

Projected Year Value (2028)

US $178.15 BN

CAGR (2022 - 2028)

8.4%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific

According to Stratistics MRC, the Global Topical Drug Delivery Market is accounted for $109.80 billion in 2022 and is expected to reach $178.15 billion by 2028 growing at a CAGR of 8.4% during the forecast period. Topical drug delivery refers to the delivery of drugs through topical routes such as the skin, mucosa, or cavities in the body. These are applied locally to avoid the first-pass effect of the drug or for site-specific action. A topical mode of delivery offers benefits such as site-specificity, eliminating fluctuations in the levels of drugs, improved suitability for self-medication, and better compliance.

The total global cell and gene drug delivery devices market was dominated by North America and Europe, which were responsible for than 83 percent of the market all together. It was forecast that this domination will continue until 2030, although the market share in the U.S. was projected to drop some four percent. It was estimated that 60 percent of drugs in the R&D pipeline were with an injectable delivery route, thus making it the top delivery route for drugs in pipeline.

Market Dynamics:

Driver:

Growing prevalence of skin diseases

Growing prevalence of skin disorders and infections including acne, psoriasis, and eczema, rising incidences of minor skin injuries such as skin burns, increasing self-medication practices, and increased consumer spending on dermatological products such as anti-acne and anti-septic creams and gels are among the other key factors expected to drive the global topical drug delivery market. As topical drug delivery is the first line of treatment for the majority of skin diseases, the demand for advanced topical products is expected to increase in the coming years.

Restraint:

Availability of alternative modes of drug delivery

There are several alternative drug delivery modes available for patients and end users. The benefits of these alternatives over topical drug delivery form a key restraint to the growth of this market. Of these, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Furthermore, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe.

Opportunity:

Delivery of biologics through the transdermal route

The delivery of biologics through the transdermal route is one of the emerging trends in the topical drug delivery market. The transdermal delivery of large molecules as an alternative to intramuscular, subcutaneous, or intravenous routes of administration is expected to provide significant patient benefits, such as painless drug delivery and cost-effective treatment.

Threat:

Technical barriers related to skin irritation

The chance for local adverse reactions and skin irritation is a significant challenge for topical drug delivery formulation and transdermal systems. However, the emergence of novel techniques for skin permeation and the development of methods to reduce skin irritation would help widen the topical drug delivery formulations and transdermal systems market for hydrophilic compounds, macromolecules, and conventional drugs for new therapeutic indications.

The home care settings segment is expected to be the largest during the forecast period

The home care settings segment is expected to be the largest during the forecast period owing to the convenience and affordability of topical drugs for home administration. Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. In this regard, technological advancements have helped patients undergo therapies effectively and safely at home.

The dermal drug delivery (skin) segment is expected to have the highest CAGR during the forecast period

The dermal drug delivery segment is expected to witness the highest growth during the forecast period. This can be attributed to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance. Besides, dermal products have fewer regulatory requirements than ophthalmic products, where sterility testing is mandatory.

Region with largest share:

North America is projected to hold the largest market share owing to the growing product launches by various key players in the region. Due to the COVID-19 outbreak, the market is expecting to observe positive growth. This is mainly due to the novel treatment being developed. The growing burden of skin-related conditions is also expected to accelerate the market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems.



Key players in the market

Some of the key players profiled in the Topical Drug Delivery Market include Teligent Pharma, Almirall, S.A, Perrigo Pharma, Novartis AG, Bayer AG, Mylan, Merck & Co, LEO Pharma , Johnson & Johnson, Agile Therapeutics Inc., Cipla Ltd, GlaxoSmithKline, Encore Dermatology, Inc., Crescita Therapeutics Inc., Taro Pharmaceutical Industries Ltd, Bausch Health Companies, Glenmark Pharmaceuticals, and Aclaris Therapeutics, Inc.

Key developments:

In February 2021: Almirall and MC2 Therapeutics went under an exclusive agreement for the commercialization of its product 'Wynzora', a topical drug indicated against the treatment of plaque psoriasis.

In December 2020: Agile Therapeutics Inc. introduced Twirla (levonorgestrel and ethinyl estradiol) transdermal system, which is a contraceptive patch.

In August 2020: LEO Pharma received United States Food and Drug Administration approval for its delgocitinib cream for the treatment of moderate-to-severe chronic hand eczema (CHE) in adults.

In November 2018: Bausch Healthcare expanded its manufacturing facility in Rochester in order to support and fulfill the demand of its topical eye health products.

Routes of Administration Covered:
• Vaginal Drug Delivery
• Rectal Drug Delivery
• Ophthalmic Drug Delivery
• Nasal Drug Delivery
• Dermal Drug Delivery (Skin)

Products Covered:
• Liquid Formulations
• Solid Formulations
• Devices (Transdermal Drug Delivery)
• Semi-Solid Formulations

Distribution Channels Covered:
• Retail
• Direct Tenders

Facilities of Use Covered:
• Hospitals & Private Clinics
• Home Care Settings
• Burn Centers
• Other Facilities

Types Covered:
• Hard & Rigid Braces
• Hinged Braces
• Soft & Elastic Braces

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Topical Drug Delivery Market, By Route of Administration
5.1 Introduction
5.2 Vaginal Drug Delivery
5.3 Rectal Drug Delivery
5.4 Ophthalmic Drug Delivery
5.5 Nasal Drug Delivery
5.6 Dermal Drug Delivery (Skin)

6 Global Topical Drug Delivery Market, By Product
6.1 Introduction
6.2 Liquid Formulations
6.2.1 Suspensions
6.2.2 Solutions
6.3 Solid Formulations
6.3.1 Suppositories
6.3.2 Powders
6.4 Devices (Transdermal Drug Delivery)
6.4.1 Transdermal Semi-solids
6.4.2 Transdermal Patches
6.4.3 Inhaler
6.5 Semi-Solid Formulations
6.5.1 Pastes
6.5.2 Ointments
6.5.3 Lotions
6.5.4 Gels
6.5.5 Creams

7 Global Topical Drug Delivery Market, By Distribution Channel
7.1 Introduction
7.2 Retail
7.2.1 Offline
7.2.2 Online
7.3 Direct Tenders

8 Global Topical Drug Delivery Market, By Facility of Use
8.1 Introduction
8.2 Hospitals & Private Clinics
8.3 Home Care Settings
8.4 Burn Centers
8.5 Other Facilities
8.5.1 Academic & Research Institutes
8.5.2 Diagnostic Centers

9 Global Topical Drug Delivery Market, By Type
9.1 Introduction
9.2 Hard & Rigid Braces
9.3 Hinged Braces
9.4 Soft & Elastic Braces

10 Global Topical Drug Delivery Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Teligent Pharma
12.2 Almirall, S.A
12.3 Perrigo Pharma
12.4 Novartis AG
12.5 Bayer AG
12.6 Mylan
12.7 Merck & Co
12.8 LEO Pharma
12.9 Johnson & Johnson
12.10 Agile Therapeutics Inc.
12.11 Cipla Ltd
12.12 GlaxoSmithKline
12.13 Encore Dermatology, Inc.
12.14 Crescita Therapeutics Inc.
12.15 Taro Pharmaceutical Industries Ltd
12.16 Bausch Health Companies
12.17 Glenmark Pharmaceuticals
12.18 Aclaris Therapeutics, Inc.

List of Tables
1 Global Topical Drug Delivery Market Outlook, By Region (2020-2028) ($MN)
2 Global Topical Drug Delivery Market Outlook, By Route of Administration (2020-2028) ($MN)
3 Global Topical Drug Delivery Market Outlook, By Vaginal Drug Delivery (2020-2028) ($MN)
4 Global Topical Drug Delivery Market Outlook, By Rectal Drug Delivery (2020-2028) ($MN)
5 Global Topical Drug Delivery Market Outlook, By Ophthalmic Drug Delivery (2020-2028) ($MN)
6 Global Topical Drug Delivery Market Outlook, By Nasal Drug Delivery (2020-2028) ($MN)
7 Global Topical Drug Delivery Market Outlook, By Dermal Drug Delivery (Skin) (2020-2028) ($MN)
8 Global Topical Drug Delivery Market Outlook, By Product (2020-2028) ($MN)
9 Global Topical Drug Delivery Market Outlook, By Liquid Formulations (2020-2028) ($MN)
10 Global Topical Drug Delivery Market Outlook, By Suspensions (2020-2028) ($MN)
11 Global Topical Drug Delivery Market Outlook, By Solutions (2020-2028) ($MN)
12 Global Topical Drug Delivery Market Outlook, By Solid Formulations (2020-2028) ($MN)
13 Global Topical Drug Delivery Market Outlook, By Suppositories (2020-2028) ($MN)
14 Global Topical Drug Delivery Market Outlook, By Powders (2020-2028) ($MN)
15 Global Topical Drug Delivery Market Outlook, By Devices (Transdermal Drug Delivery) (2020-2028) ($MN)
16 Global Topical Drug Delivery Market Outlook, By Transdermal Semi-solids (2020-2028) ($MN)
17 Global Topical Drug Delivery Market Outlook, By Transdermal Patches (2020-2028) ($MN)
18 Global Topical Drug Delivery Market Outlook, By Inhaler (2020-2028) ($MN)
19 Global Topical Drug Delivery Market Outlook, By Semi-Solid Formulations (2020-2028) ($MN)
20 Global Topical Drug Delivery Market Outlook, By Pastes (2020-2028) ($MN)
21 Global Topical Drug Delivery Market Outlook, By Ointments (2020-2028) ($MN)
22 Global Topical Drug Delivery Market Outlook, By Lotions (2020-2028) ($MN)
23 Global Topical Drug Delivery Market Outlook, By Gels (2020-2028) ($MN)
24 Global Topical Drug Delivery Market Outlook, By Creams (2020-2028) ($MN)
25 Global Topical Drug Delivery Market Outlook, By Distribution Channel (2020-2028) ($MN)
26 Global Topical Drug Delivery Market Outlook, By Retail (2020-2028) ($MN)
27 Global Topical Drug Delivery Market Outlook, By Offline (2020-2028) ($MN)
28 Global Topical Drug Delivery Market Outlook, By Online (2020-2028) ($MN)
29 Global Topical Drug Delivery Market Outlook, By Direct Tenders (2020-2028) ($MN)
30 Global Topical Drug Delivery Market Outlook, By Facility of Use (2020-2028) ($MN)
31 Global Topical Drug Delivery Market Outlook, By Hospitals & Private Clinics (2020-2028) ($MN)
32 Global Topical Drug Delivery Market Outlook, By Home Care Settings (2020-2028) ($MN)
33 Global Topical Drug Delivery Market Outlook, By Burn Centers (2020-2028) ($MN)
34 Global Topical Drug Delivery Market Outlook, By Other Facilities (2020-2028) ($MN)
35 Global Topical Drug Delivery Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
36 Global Topical Drug Delivery Market Outlook, By Diagnostic Centers (2020-2028) ($MN)
37 Global Topical Drug Delivery Market Outlook, By Type (2020-2028) ($MN)
38 Global Topical Drug Delivery Market Outlook, By Hard & Rigid Braces (2020-2028) ($MN)
39 Global Topical Drug Delivery Market Outlook, By Hinged Braces (2020-2028) ($MN)
40 Global Topical Drug Delivery Market Outlook, By Soft & Elastic Braces (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials